151.73
price up icon1.15%   1.72
after-market アフターアワーズ: 151.73
loading
前日終値:
$150.01
開ける:
$150.87
24時間の取引高:
856.90K
Relative Volume:
0.56
時価総額:
$7.42B
収益:
$4.06B
当期純損益:
$413.08M
株価収益率:
18.94
EPS:
8.01
ネットキャッシュフロー:
$560.48M
1週間 パフォーマンス:
+2.95%
1か月 パフォーマンス:
+11.87%
6か月 パフォーマンス:
-17.81%
1年 パフォーマンス:
-26.55%
1日の値動き範囲:
Value
$148.70
$152.91
1週間の範囲:
Value
$146.00
$153.72
52週間の値動き範囲:
Value
$91.86
$254.15

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name
名前
Charles River Laboratories International Inc
Name
セクター
Healthcare (1173)
Name
電話
781-222-6000
Name
住所
251 BALLARDVALE ST, WILMINGTON, MA
Name
職員
20,100
Name
Twitter
@criverlabs
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
CRL's Discussions on Twitter

CRL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
CRL
Charles River Laboratories International Inc
151.73 7.42B 4.06B 413.08M 560.48M 8.01
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
405.46 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.54 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
536.34 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
118.01 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
157.59 27.64B 15.50B 1.33B 2.16B 7.34

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-23 アップグレード Redburn Atlantic Neutral → Buy
2025-05-14 アップグレード TD Cowen Hold → Buy
2025-05-08 アップグレード Evercore ISI In-line → Outperform
2025-03-21 ダウングレード Goldman Buy → Neutral
2025-03-04 アップグレード Citigroup Sell → Neutral
2025-03-03 アップグレード Redburn Atlantic Sell → Neutral
2025-01-22 ダウングレード William Blair Outperform → Mkt Perform
2025-01-17 ダウングレード UBS Buy → Neutral
2024-11-18 ダウングレード CLSA Hold → Underperform
2024-11-07 アップグレード CLSA Underperform → Hold
2024-10-23 開始されました CLSA Underperform
2024-10-14 開始されました Redburn Atlantic Sell
2024-10-07 ダウングレード Evercore ISI Outperform → In-line
2024-10-02 ダウングレード BofA Securities Buy → Neutral
2024-10-01 ダウングレード Citigroup Neutral → Sell
2024-08-08 ダウングレード JP Morgan Overweight → Neutral
2024-08-08 ダウングレード Robert W. Baird Outperform → Neutral
2024-06-28 ダウングレード Argus Buy → Hold
2024-06-07 開始されました Mizuho Neutral
2024-06-06 開始されました Goldman Buy
2024-02-15 ダウングレード Guggenheim Buy → Neutral
2023-09-13 開始されました TD Cowen Market Perform
2023-07-10 ダウングレード Citigroup Buy → Neutral
2023-02-23 アップグレード Guggenheim Neutral → Buy
2023-01-12 ダウングレード Jefferies Buy → Hold
2022-09-30 アップグレード Jefferies Hold → Buy
2022-08-25 開始されました Credit Suisse Outperform
2022-08-04 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-05-24 開始されました Guggenheim Neutral
2022-04-25 ダウングレード Jefferies Buy → Hold
2022-04-07 開始されました Stephens Overweight
2022-02-17 繰り返されました BofA Securities Buy
2022-02-17 アップグレード Citigroup Neutral → Buy
2022-02-17 繰り返されました Deutsche Bank Buy
2022-02-17 繰り返されました Morgan Stanley Overweight
2022-02-17 繰り返されました UBS Buy
2021-08-05 再開されました Credit Suisse Neutral
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-09-10 アップグレード Jefferies Hold → Buy
2020-07-01 アップグレード BofA Securities Neutral → Buy
2020-05-13 アップグレード UBS Neutral → Buy
2020-04-21 ダウングレード Jefferies Buy → Hold
2020-03-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-03-02 開始されました Deutsche Bank Buy
2020-02-18 アップグレード Wolfe Research Peer Perform → Outperform
2020-01-10 アップグレード Goldman Neutral → Buy
2020-01-08 開始されました Wells Fargo Overweight
2020-01-07 開始されました Citigroup Buy
2019-10-18 ダウングレード BofA/Merrill Buy → Neutral
2019-06-10 開始されました SVB Leerink Outperform
2019-04-30 再開されました Evercore ISI Outperform
2018-12-14 開始されました Deutsche Bank Buy
2018-10-09 開始されました UBS Neutral
2018-08-23 アップグレード Raymond James Mkt Perform → Outperform
2018-07-17 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-06-15 アップグレード KeyBanc Capital Mkts Sector Weight → Overweight
2018-02-14 アップグレード SunTrust Hold → Buy
すべてを表示

Charles River Laboratories International Inc (CRL) 最新ニュース

pulisher
Jun 17, 2025

Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 17, 2025
pulisher
Jun 16, 2025

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment | CRL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment - Business Wire

Jun 16, 2025
pulisher
Jun 16, 2025

Do Wall Street Analysts Like Charles River Laboratories Stock? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

Global Viral Inactivation Market | Solvent Detergent & - openPR.com

Jun 16, 2025
pulisher
Jun 14, 2025

Charles River falls after projecting 2025 revenue drop - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Medical Device Testing Market Trends | Regulatory Compliance - openPR.com

Jun 13, 2025
pulisher
Jun 13, 2025

Charles River Laboratories credit outlook lowered to stable at S&P on weak 2025 guidance - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call Transcript - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

Charles River surges after Q1 beat, guidance raise - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

FDA’s Intent To Phase Out Animal Testing Requirement Weighs Down Charles River Stock: Retail’s Disheartened - MSN

Jun 12, 2025
pulisher
Jun 11, 2025

Insiders At Charles River Laboratories International Sold US$2.8m In Stock, Alluding To Potential Weakness - simplywall.st

Jun 11, 2025
pulisher
Jun 11, 2025

Rhumbline Advisers Increases Stake in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Jun 11, 2025
pulisher
Jun 09, 2025

Transcript : Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Polen U.S SMID Company Growth Strategy Sold Charles River Laboratories International (CRL) for More Attractive Opportunities - Insider Monkey

Jun 09, 2025
pulisher
Jun 06, 2025

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.

Jun 05, 2025
pulisher
Jun 04, 2025

William Blair Remains a Hold on Charles River Labs (CRL) - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Charles River at Jefferies Conference: Strategic Moves Amid Challenges By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Transcript : Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10 - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Charles River Laboratories To Present At Jefferies Global Conference; Webcast At 10:30 AM ET - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

Cell Banking Outsourcing Market To Witness Substantial Growth, - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Charles River Stock May Gain From Extended CHDI Research Deal on HD - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Charles River Laboratories International Inc (CRL) Shares Up 3.0 - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Charles River at William Blair Conference: Navigating Challenges with Innovation - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Charles River Laboratories To Present At William Blair Growth Stock Conference; Webcast At 11:00 AM - Nasdaq

Jun 03, 2025
pulisher
Jun 02, 2025

Charles River Laboratories to Present at William Blair and Jefferies Conferences - BioSpace

Jun 02, 2025
pulisher
Jun 02, 2025

Charles River Laboratories to Present at William Blair and Jeffe - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Charles River Laboratories to Present at William Blair and Jefferies Conferences | CRL Stock News - GuruFocus

Jun 02, 2025
pulisher
May 30, 2025

Charles River Laboratories International, Inc. (CRL): A Bull Case Theory - Insider Monkey

May 30, 2025
pulisher
May 28, 2025

Charles River Laboratories, CHDI Foundation Extend Collaboration - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research - BioSpace

May 28, 2025
pulisher
May 28, 2025

Charles River Laboratories International Extend Drug Discovery Partnership With CHDI Foundation - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Charles River Labs extends Huntington’s disease research pact By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Charles River (CRL) and CHDI Foundation Extend Partnership for H - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Charles River Labs extends Huntington’s disease research pact - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Charles River (CRL) and CHDI Foundation Extend Partnership for Huntington's Drug Discovery | CRL Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Charles River Laboratories (CRL) and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research - StreetInsider

May 28, 2025
pulisher
May 25, 2025

Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT - MSN

May 25, 2025
pulisher
May 25, 2025

Should You Continue to Hold Charles River Stock in Your Portfolio? - MSN

May 25, 2025
pulisher
May 24, 2025

There's No Escaping Charles River Laboratories International, Inc.'s (NYSE:CRL) Muted Revenues Despite A 25% Share Price Rise - simplywall.st

May 24, 2025
pulisher
May 23, 2025

Charles River Laboratories International, Inc. (CRL) Extends CEO's Employment Agreement - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Charles River (CRL) Upgraded to Buy Amid Strategic Developments | CRL Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Redburn raises Charles River Labs to buy, cuts price target to $182 - Investing.com Nigeria

May 23, 2025
pulisher
May 23, 2025

Redburn raises Charles River Labs to buy, cuts price target to $182 By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

Charles River Laboratories International CEO James C. Foster's Employment Extended Until February 2027SEC Filing - marketscreener.com

May 23, 2025

Charles River Laboratories International Inc (CRL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Charles River Laboratories International Inc (CRL) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
MASSARO GEORGE
Director
May 15 '25
Sale
137.57
140
19,260
5,575
MASSARO GEORGE
Director
May 14 '25
Sale
140.73
140
19,703
5,715
LaPlume Joseph W
EVP, Corp Strategy & Develop
May 13 '25
Sale
145.41
500
72,705
19,513
diagnostics_research DGX
$179.63
price up icon 1.01%
diagnostics_research WAT
$349.04
price down icon 0.96%
diagnostics_research LH
$262.51
price up icon 0.74%
$168.94
price up icon 0.58%
diagnostics_research MTD
$1,174.72
price down icon 0.83%
diagnostics_research IQV
$157.59
price up icon 0.08%
大文字化:     |  ボリューム (24 時間):